Format

Send to

Choose Destination
Int J Antimicrob Agents. 2007 Sep;30(3):210-2. Epub 2007 Jun 12.

Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control.

Author information

1
Department of Internal Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, and Medical College of Virginia Hospitals, 1101 East Broad Street, P.O. Box 980663, Richmond, VA 23298, USA. rwenzel@mcvh-vcu.edu

Abstract

The emergence and clonal expansion of strains of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have created new challenges with their entrance to hospitals. The increased virulence of CA-MRSA in concert with the depressed immunity of inpatients may cause added morbidity and mortality expected from healthcare-associated infections. Questions about changing prophylactic and empirical therapy as well as the use of intravenous immunoglobulin for life-threatening infections are addressed.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center